MATSE 403 Paper
Transcript of MATSE 403 Paper
8/8/2019 MATSE 403 Paper
http://slidepdf.com/reader/full/matse-403-paper 1/5
MATSE 403 ‐ Final Paper
Part III: State ‐of ‐the ‐art Advances/ Production/ Synthesis
Daniel Cook
Introduction
As mentioned in previous portions of this paper, Magnesium is an ideal candidate as a biodegradable
material. It is highly biocompatible (approximately three ‐hundred milligrams per day is the
recommended daily intake), has a high primary stability, and has a superior strength to weight ratio.
Even with such promising characteristics Magnesium has yet to make a significant contribution in the field biomaterials. A major factor preventing its application is its high rate of corrosion in‐vivo. High rates
of corrosion are the source of two problems. First, magnesium corrodes in‐vivo through the following
equation:
2 ↔
As can be seen from this one mole of magnesium produces one mole of hydrogen gas, causing a large accumulation of subcutaneous gas bubbles. The second issue with high corrosion rates is the tissue the
implant is supporting will not have sufficient time to heal before the implant completely corrodes. This
is most evident in bone fracture and stent use. Both bone and arteries require approximately six weeks to fully heal, meaning the implant must last this amount of time. This section of the paper will look at what methods are being investigated to control the problem of rapid corrosion.
Alloying
Alloying magnesium with more corrosion resistant materials is the first method being investigated. Two of the main alloys currently being researched are WE43 and AZ91D. The composition of these alloys are as follows:
WE43Element Weight Percent Yttrium 4.11 Neodymium 2.28 Rhenium 0.98 Zirconium 0.45
Dysprosium 0.27 Magnesium 91.91
AZ91DElement Weight Percent Aluminum 8.1 Zinc 1 Silicon 0.3
8/8/2019 MATSE 403 Paper
http://slidepdf.com/reader/full/matse-403-paper 2/5
Manganese 0.13 Magnesium 90.47
There are two methods used to produce these alloys, depending on the intended application. The first method is die casting. This method is used when the implant needs to be a bulk metal, such as when
the implant is used for bone repair. Die casting involves heating the metals until they reach a molten state. Pressure is then used to force this liquid into a mold where it cools and hardens, forming the
alloy.
The second method for production is electron beam physical vapor deposition. This method is preferred when the alloy must be very thin (micrometers range), or when the implant must have a very specific surface morphology. These requirements are common to stent use. In this method electrons ejected
from a charged tungsten filament bombard the metals, causing them to vaporize. The vapor containing
the metals then precipitates, forming a thin solid alloy.
The purpose of adding these metals to pure magnesium is that they provide electrochemical protection, as well as acting as hardeners. From an electrochemical perspective, all of the listed alloying metals are
more noble than magnesium thus providing cathodic protection. From a physical point ‐of ‐view many of the metals, specifically aluminum, zinc, and the rare earth metals cause solid solution strengthening.
Solid solution strengthening helps prevent dislocations from easily sliding, thus increasing the yield strength of the material.
The benefit of alloying can be seen by looking at table x which displays the experimental corrosion rate
of both WE43 and AZ91D tested in simulated body fluid at thirty seven degrees Celsius.
Alloy Corrosion Rate (mm/year) AZ91D 2.8 WE43 6.9 Pure Magnesium 105
Coatings It is immediately apparent that the addition of alloying elements significantly decreases the rate of corrosion. However even with such drastic drops in corrosion rate, some issues still remain. While bulk
metal applications can typically be made thicker to increase the amount of time before total
degradation, applications of thin films typically have very tight space requirements meaning increasing the thickness of the implant is not viable. This is where another, more recent, research topic in magnesium biomaterials has taken hold. This new topic involves the formation of a very thin coating on top of the magnesium implant.
8/8/2019 MATSE 403 Paper
http://slidepdf.com/reader/full/matse-403-paper 3/5
The idea make the
corrode fi The first
magnesiusolution f
Experime
showed atable y.
Material Pure MaAZ91D Magnesiu
Another
increases
The hydr
to keep t
ehind provi
coating mat
rst, saving th
oating being
m thin films. or twenty ‐fo
ntal corrosio significant d
nesium
m with Hydr
enefit to the
cell prolifera
xide coating e pH in a via
ing a thin su
rial more co
e magnesiu
investigated
It is formed r hours. Th
rate measu
ecrease in co
oxide Coatin
hydroxide ction on its su
accomplishe
ble range, as
rface coating
rrosion resist implant fro
is magnesiu
by soaking a coating is f
2
rements for rrosion, even
ating is not
rface. This ca
s this cell pro
well as provi
on top of thant than sta
immediate
hydroxide.
magnesium rmed throu
→
hin film mag when comp
Corrosi105 2.8 0.252
nly the bioc
n be seen in
liferation by ding a better
e magnesium
dard magne corrosion.
This coating
hin film in oh the followi
nesium treat
ared to untr
on rate (mm
ompatibility
figure z:
decreasing h surface for
or magnesi
sium. This co
is very easy
e molar soding reaction:
ed with the ated alloys,
/year)
of the coatin
ydrogen gas ell adhesion.
m alloys is tating will the
to synthesize
ium hydroxid
ydroxide co
ummarized i
, but it actu
evolution, h While the
n
on
e
ting n
lly
lping
8/8/2019 MATSE 403 Paper
http://slidepdf.com/reader/full/matse-403-paper 4/5
coating st
over untr
The seco
first appl
then immthis coati
This coati
little sup
following magnesiu
This figur
magnesiu
applied.
In additio
advantag
expandin
environm
coating hcan be ill
ill lacks the ceated magne
d coating ga
ing a hydrox
ersed in a fog is:
ng is still in itorting corro
figure comp
m:
shows that m. The coat
oth these fa
n to the theo
. In applica and contra
ent to by ‐pa
wever, thes
strated as:
ell density of
sium.
rnering atten
ide coating aty percent h
s infancy sta
ion rate evid
res the brea
the breakdo
d sample al
ctor generall
retical reduc
ions such as ting of blood
s the coatin
e cracks natu
the simulate
tion is a mag described adrofluoric a
es in terms ence. Howe
kdown volta
n voltage is o has a lowe
y correspond
tion in corro
stents, the c vessels caus and directly
rally passiva
d body fluid,
nesium fluor
bove. Once
id solution f
2 →
f being used
er some ele
es of pure m
much higher
r current den to a lower c
ion rate, the nstant mech
e cracks to f attack the pe and form t
it still provid
ide coating. his coating i
or ninety ‐six
as a corrosi
ctrochemical agnesium to
for the fluor
sity through
orrosion rate
fluoride coa
anical strain rm in the co
ure magnesi
he hydroxide
es a significa
This coating i applied to t
hours. The r
n inhibitor, analysis has the fluoride
ide coating tout the rang in practice.
ting also pro
put on the iating. These
m implant. coating expl
nt improvem
s produced bhe implant, ieaction form
o there is ve
been done. coated
an the unco of voltages
ides a mech
plant from tcracks allow
ith the fluo
ained above.
ent
y is
ing
ry he
ated
nical he the
ride This
8/8/2019 MATSE 403 Paper
http://slidepdf.com/reader/full/matse-403-paper 5/5
Conclusi
As can be
rate of co
as a biod
stage. Ad
coatings i
on
seen, alloyin
rrosion to an
gradable ma
ditional corr
n‐vivo to pro
g and the ap acceptable lterial. Howe
sion data fove biocompa
plications of evel. These ver more res
r the coating
tibility.
oatings to pdvances giv
earch must b must be ob
ure magnesi great promi
e done befo
tained, as we
m can signifi
se to the fut
re it reaches
ll as testing
icantly alter tre of magne
a commercia
f the alloys
he sium l
nd